Skip to main content
Lawrence Eichenfield, MD, Dermatology, San Diego, CA

Lawrence F. Eichenfield MD

Pediatric Dermatology


Professor of Dermatology and Pediatrics, UCSD

Join to view full profile
  • 3030 Childrens WaySan Diego, CA 92123

  • Phone+1 858-966-6795

Dr. Eichenfield is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Dermatology, 1988 - 1991
  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaResidency, Pediatrics, 1984 - 1987
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1984

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1990 - 2027
  • PA State Medical License
    PA State Medical License 1986 - 1992
  • Dermatology
    American Board of Dermatology Dermatology
  • Pediatric Dermatology
    American Board of Dermatology Pediatric Dermatology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2004-2014
  • Top Doctors:San Diego Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy and Safety of Baricitinib Combined with Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis  
    Lawrence F Eichenfield, Eric L Simpson, JAMA Dermatology
  • Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults with Molluscum Contagiosum  
    Lawrence F Eichenfield, Wendy Mcfalda, Pearl Kwong, JAMA Dermatology
  • Atopic Dermatitis: New Developments  
    Lawrence F Eichenfield, Allison M Han, ScienceDirect

Lectures

  • Atopic Dermatitis 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
  • Atopic Dermatitis 
    Symposia Medicus, Big Sky, Montana - 2/19/2013
  • Atopic Dermatitis 
    10/13/2014

Press Mentions

  • FDA Accepts sNDA for Roflumilast Cream 0.05% in Infants with AD
    FDA Accepts sNDA for Roflumilast Cream 0.05% in Infants with ADJuly 8th, 2026
  • FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (Roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months
    FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (Roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 MonthsJuly 8th, 2026
  • Zoryve Cream 0.05% Approved for Atopic Dermatitis in 2- to 5-Year-Olds
    Zoryve Cream 0.05% Approved for Atopic Dermatitis in 2- to 5-Year-OldsOctober 10th, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: